Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,312.08
+2,994.96
(+6.33%)
MONEY
Best savings accounts that offer above inflation rates
Where to find a top-rated deal that works for you
Atara Biotherapeutics, Inc. (ATRA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6700
+0.0197
(+3.03%)
At close: 04:00PM EDT
0.6848
+0.01
(+2.21%)
After hours:
06:49PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,573
8,573
63,573
20,340
0
Cost of revenue
8,886
8,886
0
-
-
Gross profit
-313
-313
63,573
-
-
Operating expenses
Research development
224,785
224,785
272,533
282,001
244,650
Selling general and administrative
50,908
50,908
71,553
78,801
64,402
Total operating expenses
275,693
275,693
344,086
360,802
309,052
Operating income or loss
-276,006
-276,006
-280,513
-340,462
-309,052
Interest expense
5,285
5,285
373
-
-
Total other income/expenses net
-246
-246
49,537
-
-
Income before tax
-276,111
-276,111
-228,290
-340,095
-306,605
Income tax expense
15
15
12
46
15
Income from continuing operations
-276,126
-276,126
-228,302
-340,141
-306,620
Net income
-276,126
-276,126
-228,302
-340,141
-306,620
Net income available to common shareholders
-276,126
-276,126
-228,302
-340,141
-306,620
Basic EPS
-2.78
-
-2.24
-3.63
-4.15
Diluted EPS
-2.78
-
-2.24
-3.63
-4.15
Basic average shares
104,670
-
101,990
93,670
73,973
Diluted average shares
104,670
-
101,990
93,670
73,973
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.